Functional significance of cysteine residues in the δ opioid receptor studied by site-directed mutagenesis

Canadian Journal of Physiology and Pharmacology

Volumn 76, Issue 3, 1998, Pages 269-277

  Ehrlich, George K ^a   Andria, Matthew L ^a   Zheng, Xin ^b   Kieffer, Brigitte ^c   Gioannini, Theresa L ^a,d   Hiller, Jacob M ^a   Rosenkranz, Jeremy E ^a   Veksler, Boris M ^a   Zukin, R Suzanne ^b   Simon, Eric J ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Ecl Sup de Biotechnologie   (France)

^d CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cysteine; Opioid receptor; Site directed mutagenesis; Sulfhydryl

Indexed keywords

DELTA OPIATE RECEPTOR; DISULFIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; THIOL GROUP;

AMINO ACID COMPOSITION; ANIMAL CELL; ARTICLE; BINDING SITE; CELL MEMBRANE; CHO CELL; CONTROLLED STUDY; FLUORESCENCE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; LIGAND BINDING; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS; STEREOSPECIFICITY;

ALANINE; AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; CYSTEINE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN CONFORMATION; RECEPTORS, OPIOID, DELTA; SERINE;

EID: 15144344557     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/cjpp-76-3-269     Document Type: Article

References (31)

1. Befort, K., Tabbara, L., Bausch, S., Chavkin, C., Evans, C.J., and Kieffer, B.L. 1996. The conserved aspartate residue in the third putative transmembrane domain of the δ-opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site. Mol. Pharmacol. 49: 216-223.
2. Dixon, R.A.F., Sigal, I.S., Candelore, M.R., Register, R.B., Scattergood, W., Rands, E., and Strader, C.D. 1987. Structural features required for ligand binding to the beta-adrenergic receptor. EMBO J. 6: 3269-3275.
3. 2-adrenergic receptor. Biochemistry, 29: 2335-2342.
4. Evans, C.J., Keith, D.E.J., Morrison, H., Magendzo, K., and Edwards, R.H. 1992. Cloning of a delta opioid receptor by functional expression. Science (Washington, D.C.), 258: 1952-1955.
5. Fraser, C.M. 1989. Site-directed mutagenesis of beta-adrenergic receptors. J. Biol. Chem. 264: 9266-9270.
6. Gioannini, T.L., Liu, Y.F., Park, Y.H., Hiller, J.M., and Simon, E.J. 1989. Evidence for the presence of disulfide bridges in opioid receptors essential for ligand binding. Possible role in receptor activation. J. Mol. Recognit. 2: 44-48.
7. Javitch, J.A., Li, X., Kaback, J., and Karlin, A. 1994. A cysteine residue in the third membrane-spanning segment of the human D2 dopamine receptor is exposed in the binding site crevice. Proc. Natl. Acad. Sci. U.S.A. 91: 10 355-10 359.
8. Karnik, S.S., and Khorana, H.G. 1990. Assembly of functional rhodopsin requires a disulfide bond between cysteine residues 110 and 187. J. Biol. Chem. 265: 17 520-17 524.
9. Karnik, S.S., Sakmar, T.P., Chen, H.B., and Khorana, H.G. 1988. Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin. Proc. Natl. Acad. Sci. U.S.A. 85: 8459-8463.
10. Kieffer, B.L., Befort, K., Gaveriaux-Ruff, C., and Hirth, C.G. 1992. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U.S.A. 89: 12 048-12 052.
11. Knapp, R.J., Malatynska, E., Fang, L., Xiaoping, L., Babin, E., Nguyen, M., Santoro, G., Varga, E.V., Hruby, V.J., Roeske, W.R., and Yamamura, H.I. 1994. Identification of a human delta opioid receptor:cloning and expression. Life Sci. 54: PL 463-469.
12. Knapp, R.J., Malatynska, E., Collins, N., Fang, L., Wang, J.Y., Hruby, V.J., Roeske, W.R., and Yamamura, H.I. 1995. Molecular biology and pharmacology of cloned opioid receptors. FASEB J. 9: 516-525.
13. Kong, H., Raynor, K., Yasuda, K., Moe, S.T., Portoghese, P.S., Bell, G.I., and Reisine, T. 1993. A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding. J. Biol. Chem. 268: 23 055-23 058.
14. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature (London), 227: 680-685.
15. Law, P.Y., McGinn, T.M., Wick, M.J., Erickson, L.J., Evans, C.J., and Loh, H.H. 1994. Analysis of delta-opioid receptor activities stably expressed in CHO cell lines: function of receptor density? J. Pharmacol. Exp. Ther. 271: 1686-1694.
16. Meng, F., Hoversten, M.T., Thompson, R.C., Taylor, L., Watson, S.J., and Akil, H. 1995. A chimeric study of the molecular basis of affinity and selectivity of the κ and the δ opioid receptors potential role of extracellular domains. J. Biol. Chem. 270: 12 730-12 736.
17. Mullikin-Kilpatrick, D., Larsen, N.E., and Blume, A.J. 1983. Protection of opiate receptors in NG108-15 against modification by N-ethylmaleimide. J. Neurosci. 3: 145-152.
18. Ofri, D., and Simon, E.J. 1992. Sulfhydryl groups on opioid receptors revisited: evidence for two sulfhydryl groups at or near the active site of the mu opioid receptor. Receptor, 2: 109-119.
19. Ofri, D., Ritter, A.M., Liu, Y.F., Gioannini, T.L., Hiller, J.M., and Simon, E.J. 1992. Characterization of solubilized opioid receptors: reconstitution and uncoupling of guanine nucleotide-sensitive agonist binding. J. Neurochem. 58: 628-635.
20. Pasternak, G.W., Wilson, H.A., and Snyder, S.H. 1975. Differential effects of protein-modifying reagents on receptor binding of opiate agonists and antagonists. Mol. Pharmacol. 11: 340-351.
21. Prather, P.L., McGinn, T.M., Erickson, L.J., Evans, C.J., Loh, H.H., and Law, P.Y. 1994. Ability of delta opioid receptors to interact with multiple G proteins is independent of receptor density. J. Biol. Chem. 269: 21 293-21 302.
22. Shahrestanifar, M., Wang, M.M., and Howells, R.D. 1996. Studies on inhibition of mu and delta opioid receptor binding by dithiothreitol and N-ethylmaleimide. J. Biol. Chem. 271: 5505-5512.
23. Simon, E.J., and Groth, J. 1975. Kinetics of opiate receptor inactivation by sulfhydryl reagents: evidence for conformational change in presence of sodium ions. Proc. Natl. Acad. Sci. U.S.A. 72: 2404-2407.
24. Simon, E.J., and Hiller, J.M. 1994. Opioid peptides and opioid receptors. In Basic neurochemistry: molecular, cellular, and medical aspects. Edited by G.J. Siegel, B.W. Agranoff, R.W. Albers, and P.B. Molinoff, Raven Press Ltd., New York. pp. 321-339.
25. 3H-etorphine to rat brain homogenate. Proc. Natl. Acad. Sci. U.S.A. 70: 1947-1949.
26. Smith, J.R., and Simon, E.J. 1980. Selective protection of stereospecific enkephalin and opiate binding against inactivation by N-ethylmaleimide: evidence for two classes of opiate receptors. Proc. Natl. Acad. Sci. U.S.A. 77: 281-284.
27. Surratt, C.K., Johnson, P.S., Moriwaki, A., Seidleck, B.K., Blaschak, C.J., Wang, J.B., and Uhl, G.R. 1994. Mu opiate receptor: charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J. Biol. Chem. 269: 20 548-20 553.
28. Towbin, H., Staehelin, T., and Gordon, J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76: 4350-4354.
29. Wang, W.W., Shahrestanifar, M., Jin, J., and Howells, R.D. 1995. Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. Proc. Natl. Acad. Sci. U.S.A. 92: 12 436-12 440.
30. Watson, S., and Arkinstall, S. 1994. The G-protein linked receptor facts book. Academic Press, New York.
31. Zhu, J., Yin, J., Law, P.Y., Claude, P.A., Rice, K.C., Evans, C.J., Chen, C., Yu, L., and Liu-Chen, L.-Y. 1996. Irreversible binding of cis(+)-3-methylfentanyl isothiocyanate to the δ opioid receptor and determination of its binding domain. J. Biol. Chem. 271: 1430-1434.